A research work to evaluate the efficacy of two local anesthetic injections given by two different techniques in patients having tooth pain

Phase 4

Completed

• Conditions: Symptomatic irreversible pulpitis in mandibular first or second molars

• Registration Number: CTRI/2019/05/018985
• Lead Sponsor: Kanaga priyaa V

Brief Summary

The aim of this prospective randomized double blind  trial is to  evaluate the anaesthetic efficacy of 4% articaine given as supplementary  buccal infiltration after a failed 2% lignocaine which will be given either as inferior alveolar nerve block or Gow Gates  nerve block. 

114 Patients with symptomatic irreversible pulpitis in mandibular first or second molar will be selected. Patients will be randomly assigned into 2 groups according to the injection method as follows: in group I (n=57) -  patients will receive Inferior alveolar nerve block, in group II (n=57) - patients will receive Gow Gates nerve block. 3.6 ml of 2% lignocaine with 1:80,000 epinephrine will be injected according to their assigned groups. After 15 minutes , the success of the anaesthetic technique will be evaluated in their respective groups and endodontic treatment will be initiated. Pain during the endodontic treatment will be assessed using the Heft -Parker Visual analog scale. Patients having inadequate pulpal anaesthesia will receive 0.9 ml of 4% articaine with 1:1,00,000 epinephrine as buccal infiltration. After 10 minutes, endodontic treatment will be reinitiated and pain scores will be recorded.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-05-20
• Study Completion: 2019-08-16
• Last Update Posted: 2019-08-24

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

Systemically healthy patients patients with symptomatic irreversible pulpitis in mandibular molars Absence of any periapical radiolucency on radiograph except for a widening of periodontal ligament A vital pulp at access cavity preparation Ability to understand the use of pain scales.

Exclusion Criteria

Allergy to local anesthetics, pregnancy, the use of any medications such as sedatives,antianxiety,antidepressants or analgesics that might influence pain assessment, the presence of active pathosis in the area of injection, the inability to give written informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assesing the HP-VAS pain score after 2 primary injections	During the treatment

Secondary Outcome Measures

Name	Time	Method
Assesing the HP-VAS pain score after supplementary secondary injection	During the treatment

Trial Locations

Locations (1)

Adhiparasakthi dental college and hospital Melmaruvathur; 🇮🇳 Kancheepuram, TAMIL NADU, India

Adhiparasakthi dental college and hospital Melmaruvathur

🇮🇳Kancheepuram, TAMIL NADU, India

Kanaga Priyaa V

Principal investigator

9486689653

kanagapriyaa.vellingiri@gmail.com